All Studies

Cirsium japonicum var. Maackii Improves Cognitive Impairment under Amyloid Beta(25-35)-Induced Alzheimer's Disease Model.

Researchers studied the protective effects of an herbal medicine called CJM on mice with Alzheimer's disease (AD). They focused on the ethyl acetate fraction from CJM (ECJM), which has anti-inflammatory properties, and found that it improved the mice's spatial and object recognition memory, as well as their learning and memory abilities. The ECJM also inhibited lipid peroxidation and nitric oxide production, indicating that it improves cognitive impairment by reducing oxidative stress. This study suggests that CJM could be used as a treatment for AD and may have potential as a functional food material.

Pang QQ et al (2022).
Biomed Res Int.
PubMed:
35036433

Dose dependent anticonvulsant activity of Morus nigra in strychnine induced seizures model.

The study evaluated the anti-seizure activity of Morus nigra (black mulberry) in different doses. Groups of rats were given different doses of Morus nigra for 15 days prior to being administered strychnine. Results showed significant seizure protection, particularly in the 500mg/kg dose group, with delayed latency of seizures, decrease in frequency, and decreased duration of jerks. The anticonvulsant activity could be due to potentiation of both Gabaergic and glycinergic activities and the antioxidant activity of Morus nigra could serve as a non-pharmacological treatment for seizure management.

Zehra T, Sarfaraz S and Ikram R (2021).
Pak J Pharm Sci.
PubMed:
35034877